NewLink down nearly 11% after downgrade

Shares of NewLink Genetics (NLNK -10.6%) are down today, continuing its sharp reversal from Friday's high of $53.48, on a Robert W. Baird downgrade  to Neutral.

Shares are currently trading just under $40, down 25% from the peak of euphoria last week.

Investors expect the company to report its Q4 and FY13 results today.

Shares were up 155% year-to-date prior to the reversal.

Mutual fund ownership has increased from 104 to 124 over the past 4 quarters.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs